InnoSer België

Foundation date

01/01/2012

Sector

#Biotechnology / R&D Services

Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting discovery and preclinical development of drugs. InnoSer’s offerings include a proprietary PDX/O screening platform for oncology, a unique ADPKD mouse model for nephrology, and a fully characterized midbrain organoid model for Parkinson’s disease. InnoSer also provides in vivo imaging, pathology and genetically engineered mouse model services including colony management, cryopreservation, and sanitation/rederivation.

Upcoming events

News by InnoSer België

  • InnoSer welcomes Wim Tiest as its Chief Technology Officer

    Thursday April 16th 2020

  • InnoSer continues to deliver critical in-vivo and in-vitro services

    Friday March 20th 2020